Tian Tan Bio: Net profit in 2025 is expected to decrease by 29.59% year-on-year, and plans to issue a dividend of 0.5 yuan.

Tiantan Biotechnology disclosed its annual report on March 27, achieving operating income of 6.168 billion yuan in 2025, a year-on-year increase of 2.26%; net profit attributable to shareholders was 1.091 billion yuan, a year-on-year decrease of 29.59%; basic earnings per share were 0.55 yuan. The company plans to distribute a cash dividend of 0.5 yuan for every 10 shares. During the reporting period, the increase in sales volume led to an increase in operating income compared to the same period last year; factors such as a decrease in product sales prices from the same period last year, an increase in impairment provisions due to changes in credit policies, and a decrease in interest income led to a year-on-year decrease in net profit attributable to shareholders.